Cannabis-Fed Mice Showed Temperature Tolerance Without Detected Brain Radiolabel Changes

A 1973 mouse study found tolerance to THC hypothermia without a detected change in brain radioactivity assigned to THC or its metabolites. The same exposure history did not produce tolerance on an immobility measure.

Voluntary consumption preceded an injected challenge

Mice consumed cannabis in milk for fifteen days before receiving radiolabeled THC intravenously. The exposure route and later challenge route differed. This was neither ordinary dietary endocannabinoid signaling nor a modern consumer-product trial.

Two endpoints gave different answers

Cooling became tolerant, while the immobility index remained responsive. The result limits a general claim that the animals had become insensitive to THC. It also demonstrates why one physiological response cannot stand in for all behavioral effects.

The chemical finding constrained a metabolic explanation

Researchers detected no corresponding change in brain radioactivity assigned to the parent compound or metabolites. They concluded that altered metabolism or distribution did not explain the hypothermic tolerance in this model. That assay-specific result does not exclude every exposure difference at every time or establish a modern active-THC concentration threshold.

The study provides a functional-versus-chemical comparison after voluntary cannabis intake. It does not determine human impairment from a measured concentration or establish that tolerance always occurs without pharmacokinetic change. The particular endpoint, matrix and analytical method remain central.

Related: interpreting cannabis tolerance claims.

Research cited

Lawrence DK; Pertwee RG. Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol. British journal of pharmacology (1973). doi:10.1111/j.1476-5381.1973.tb08388.x. Findings discussed from the study abstract.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

A CBD Performance Meta-Analysis Found a Small Pooled Effect Driven More by Subjective Sedation

A 2024 meta-analysis found a small overall CBD–placebo performance difference, with larger effects on subjective measures such as sedation than on objective tasks. Reporting only the pooled result would conceal that important distinction. The analysis concerned acute controlled exposure Sixteen trials contributed to the primary synthesis of effects within eight…

Spread the love

Read Article: A CBD Performance Meta-Analysis Found a Small Pooled Effect Driven More by Subjective Sedation

Portable THC Reviews Count Laboratory Methods, Prototypes and Commercial Devices as Different Categories

A 2024 systematic review included 89 studies across laboratory techniques, portable sensor research and commercial devices. That total should not be presented as 89 independently validated portable THC products. The study categories describe different maturity levels The review identified 57 studies of conventional separation techniques, alongside optical and electrochemical sensor…

Spread the love

Read Article: Portable THC Reviews Count Laboratory Methods, Prototypes and Commercial Devices as Different Categories

Eyelid Tremor and Impaired Visual Control Are Different Findings in Cannabis Eye-Movement Research

A systematic review distinguished an eyelid sign associated with cannabis consumption from eye-movement functions relevant to impairment. An exposure-associated observation should not automatically be treated as a direct measure of visual attention or motor control. The evidence included three study categories The review included 20 articles spanning acute dosing experiments,…

Spread the love

Read Article: Eyelid Tremor and Impaired Visual Control Are Different Findings in Cannabis Eye-Movement Research

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us